Literature DB >> 10331650

Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication.

C M Simbulan-Rosenthal1, D S Rosenthal, S Iyer, H Boulares, M E Smulson.   

Abstract

We have focused on the roles of PARP and poly(ADP-ribosyl)ation early in apoptosis, as well as during the early stages of differentiation-linked DNA replication. In both nuclear processes, a transient burst of PAR synthesis and PARP expression occurs early, prior to internucleosomal DNA cleavage before commitment to apoptosis as well as at the round of DNA replication prior to the onset of terminal differentiation. In intact human osteosarcoma cells undergoing spontaneous apoptosis, both PARP and PAR decreased after this early peak, concomitant with the inactivation and cleavage of PARP by caspase-3 and the onset of substantial DNA and nuclear fragmentation. Whereas 3T3-L1, osteosarcoma cells, and immortalized PARP +/+ fibroblasts exhibited this early burst of PAR synthesis during Fas-mediated apoptosis, neither PARP-depleted 3T3-L1 PARP-antisense cells nor PARP -/- fibroblasts showed this response. Consequently, whereas control cells progressed into apoptosis, as indicated by induction of caspase-3-like PARP-cleavage activity, PARP-antisense cells and PARP -/- fibroblasts did not, indicating a requirement for PARP and poly(ADP-ribosyl)ation of nuclear proteins at an early reversible stage of apoptosis. In parallel experiments, a transient increase in PARP expression and activity were also noted in 3T3-L1 preadipocytes 24 h after induction of differentiation, a stage at which approximately 95% of the cells were in S-phase, but not in PARP-depleted antisense cells, which were consequently unable to complete the round of DNA replication required for differentiation. PARP, a component of the multiprotein DNA replication complex (MRC) that catalyzes viral DNA replication in vitro, poly(ADP-ribosyl)ates 15 of approximately 40 MRC proteins, including DNA pol alpha, DNA topo I, and PCNA. Depletion of endogenous PARP by antisense RNA expression in 3T3-L1 cells results in MRCs devoid of any DNA pol alpha and DNA pol delta activities. Surprisingly, there was no new expression of PCNA and DNA pol alpha, as well as the transcription factor E2F-1 in PARP-antisense cells during entry into S-phase, suggesting that PARP may play a role in the expression of these proteins, perhaps by interacting with a site in the promoters for these genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331650

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  67 in total

1.  Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells.

Authors:  B E Pearson; H P Nasheuer; T S Wang
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Influence of poly(ADP-ribose) polymerase on the enzymatic synthesis of SV40 DNA.

Authors:  T Eki; J Hurwitz
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

3.  TFIIF, a basal eukaryotic transcription factor, is a substrate for poly(ADP-ribosyl)ation.

Authors:  J M Rawling; R Alvarez-Gonzalez
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis.

Authors:  C Nosseri; S Coppola; L Ghibelli
Journal:  Exp Cell Res       Date:  1994-06       Impact factor: 3.905

5.  Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells.

Authors:  T Chiba; S Takahashi; N Sato; S Ishii; K Kikuchi
Journal:  Eur J Immunol       Date:  1996-05       Impact factor: 5.532

6.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Authors:  Z Q Wang; B Auer; L Stingl; H Berghammer; D Haidacher; M Schweiger; E F Wagner
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

7.  CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis.

Authors:  J Schlegel; I Peters; S Orrenius; D K Miller; N A Thornberry; T T Yamin; D W Nicholson
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

8.  Effects of 6-aminonicotinamide on cell growth, poly(ADP-ribose) synthesis and nucleotide metabolism.

Authors:  D Hunting; B Gowans; J F Henderson
Journal:  Biochem Pharmacol       Date:  1985-11-15       Impact factor: 5.858

9.  Proliferation is required for induction of terminal differentiation of Friend erythroleukemia cells.

Authors:  L L Spriggs; S M Hill; J R Jeter
Journal:  Biochem Cell Biol       Date:  1992-07       Impact factor: 3.626

10.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  32 in total

1.  Effect of luteolin on the methylation status of the OPCML gene and cell growth in breast cancer cells.

Authors:  Xinmin Dong; Jian Zhang; Fan Yang; Jing Wu; Rui Cai; Tian Wang; Jiren Zhang
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

2.  Cytotoxicity of ORF3 proteins from a nonpathogenic and a pathogenic porcine circovirus.

Authors:  Mark Chaiyakul; Karolynn Hsu; Rkia Dardari; Frank Marshall; Markus Czub
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

3.  Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis.

Authors:  K M Detjen; K Farwig; M Welzel; B Wiedenmann; S Rosewicz
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

4.  Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission.

Authors:  A A Pieper; S Blackshaw; E E Clements; D J Brat; D K Krug; A J White; P Pinto-Garcia; A Favit; J R Conover; S H Snyder; A Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

5.  Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; R Luo; J H Li; J Zhang; M E Smulson
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

6.  Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin.

Authors:  Alessandro E Caccamo; Maurizio Scaltriti; Andrea Caporali; Domenico D'Arca; Francesca Scorcioni; Serenella Astancolle; Massimo Mangiola; Saverio Bettuzzi
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

7.  Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells.

Authors:  Kristine M Frizzell; Matthew J Gamble; Jhoanna G Berrocal; Tong Zhang; Raga Krishnakumar; Yana Cen; Anthony A Sauve; W Lee Kraus
Journal:  J Biol Chem       Date:  2009-10-07       Impact factor: 5.157

8.  Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cells.

Authors:  E G Russell; E C O'Sullivan; C M Miller; J Stanicka; F O McCarthy; T G Cotter
Journal:  Invest New Drugs       Date:  2014-08-10       Impact factor: 3.850

9.  Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition.

Authors:  Martin S Taylor; John LaCava; Paolo Mita; Kelly R Molloy; Cheng Ran Lisa Huang; Donghui Li; Emily M Adney; Hua Jiang; Kathleen H Burns; Brian T Chait; Michael P Rout; Jef D Boeke; Lixin Dai
Journal:  Cell       Date:  2013-11-21       Impact factor: 41.582

10.  Identification of a novel, widespread, and functionally important PCNA-binding motif.

Authors:  Karin M Gilljam; Emadoldin Feyzi; Per A Aas; Mirta M L Sousa; Rebekka Müller; Cathrine B Vågbø; Tara C Catterall; Nina B Liabakk; Geir Slupphaug; Finn Drabløs; Hans E Krokan; Marit Otterlei
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.